Skip to main content

Table 9 Summary of p53 mutations detected in non-angiogenic and angiogenic NSCLC cases

From: Why some tumours trigger neovascularisation and others don’t: the story thus far

Sample ID

Sample type

Mutation location

Mutation type

Domain

Predicted effect on protein activity

104

Non-angiogenic

c.761T>TA; p.I254S

Missense

HCD IV

Damaging

105

Non-angiogenic

c.734G>GA; p.G245D

Missense

HCD IV

Damaging

121

Non-angiogenic

c.488A>AG; p.Y163C

Missense

DNA binding

Damaging

152

Non-angiogenic

c.634T>TG; p.F212 V

Missense

DNA binding

Benign

249

Non-angiogenic

c.314G>GA; p.G105D

Missense

DNA binding

Damaging

133

Angiogenic

c.511G>GT; p.E171X

Nonsense (truncated protein)

HCD III

Truncating

138

Angiogenic

c.824G>GA; p.C275Y

Missense

HCD IV

Damaging

139

Angiogenic

c.het_del216C; p.V73 Wfs48X

Frameshift (truncated protein)

Prolinerich

Truncating

141

Angiogenic

c.407A>AC; p.Q136P

Missense

HCD II

Damaging

98

Angiogenic

c.524G>GA; p.R175H

Missense

HCD III

Potentially damaging

147

Angiogenic

c.524G>GA; p.R175H

Missense

274

Angiogenic

c.471_472TC>GA; p.V157G

Missense

DNA binding

Damaging

  1. Affected domains are listed. The software used to predict the functional effect of the detected sequence changes was PolyPhen_2 (http://genetics.bwh.harvard.edu/ggi/pph2/c2ea64efde6f039a5ca76a2a264ae4f3cf922360/1121012.html )
  2. HCD highly conserved domain